A prospective pilot study comparing combined intravitreal ranibizumab and half-fluence photodynamic therapy with ranibizumab monotherapy in the treatment of neovascular age-related macular degeneration

PURPOSE: This prospective multi-center pilot study compares the use of half-fluence photodynamic therapy combined with ranibizumab with ranibizumab monotherapy for the treatment of neovascular age-related macular degeneration. METHODS: All patients presenting with untreated subfoveal neovascular age...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Patrick D, Callanan, David, Solley, Wayne, Avery, Robert L, Pieramici, Dante J, Aaberg, Tom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460704/
https://www.ncbi.nlm.nih.gov/pubmed/23055673
http://dx.doi.org/10.2147/OPTH.S31010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460704/
https://www.ncbi.nlm.nih.gov/pubmed/23055673
http://dx.doi.org/10.2147/OPTH.S31010

Ejemplares similares